Ultime notizie per Corix Bioscience (OTC:CXBS) Azioni

Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

CORIX BIOSCIENCE INC by Corix Bioscience, Inc.

Corix Bioscience Inc

WIIM

COLM

CPRI

HELE

LULU

Shares of retail and apparel stocks are trading higher as investors weigh the potential impacts of tariffs on the sector. Economic uncertainty could also cloud consumer spending outlook.

7 analysts have shared their evaluations of Voyager Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VYGR#NASDAQ">VYGR</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $21.1, a high estimate of $30.00, and a low estimate of $5.73. Highlighting a 13.28% decrease, the current average has fallen from the previous average price target of $24.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1744135258_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A clear picture of Voyager Therapeutics's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Patrick Trucchio &#x7C;HC Wainwright &amp; Co. &#x7C;Maintains &#x7C;Buy &#x7C; $30.00&#x7C;$30.00 &#x7C; 
&#x7C;Sumant Kulkarni &#x7C;Canaccord Genuity &#x7C;Lowers &#x7C;Buy &#x7C; $12.00&#x7C;$14.00 &#x7C; 
&#x7C;Patrick Trucchio &#x7C;HC Wainwright &amp; Co. &#x7C;Maintains &#x7C;Buy &#x7C; $30.00&#x7C;$30.00 &#x7C; 
&#x7C;Yanan Zhu &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $10.00&#x7C;$12.00 &#x7C; 
&#x7C;Patrick Trucchio &#x7C;HC Wainwright &amp; Co. &#x7C;Maintains &#x7C;Buy &#x7C; $30.00&#x7C;$30.00 &#x7C; 
&#x7C;Patrick Trucchio &#x7C;HC Wainwright &amp; Co. &#x7C;Maintains &#x7C;Buy &#x7C; $30.00&#x7C;$30.00 &#x7C; 
&#x7C;Pete Stavropoulos &#x7C;Cantor Fitzgerald &#x7C;Announces &#x7C;Overweight &#x7C; $5.73&#x7C;- &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Voyager Therapeutics. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Voyager Therapeutics compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Voyager Therapeutics's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Voyager Therapeutics's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/VYGR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Voyager Therapeutics analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>About Voyager Therapeutics</h2>
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
<h3>Understanding the Numbers: Voyager Therapeutics's Finances</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Voyager Therapeutics's revenue growth over a period of 3M has faced challenges. As of 31 December, 2024, the company experienced a revenue decline of approximately -93.03%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: Voyager Therapeutics's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -549.33%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Voyager Therapeutics's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of -10.95%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -8.42%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Voyager Therapeutics's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.15.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

VYGR

7 Analysts Assess Voyager Therapeutics: What You Need To Know

Expedia Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) has been analyzed by 21 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">14</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $199.1, a high estimate of $236.00, and a low estimate of $143.00. This current average reflects an increase of 4.42% from the previous average price target of $190.67. 
<img src="https://www.benzinga.com/files/images/story/2025/1744135249_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Expedia Group. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Doug Anmuth &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $170.00&#x7C;$205.00 &#x7C; 
&#x7C;Ken Gawrelski &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $143.00&#x7C;$199.00 &#x7C; 
&#x7C;Jed Kelly &#x7C;Oppenheimer &#x7C;Lowers &#x7C;Outperform &#x7C; $230.00&#x7C;$235.00 &#x7C; 
&#x7C;Greg Miller &#x7C;Truist Securities &#x7C;Raises &#x7C;Hold &#x7C; $175.00&#x7C;$163.00 &#x7C; 
&#x7C;Ronald Josey &#x7C;Citigroup &#x7C;Raises &#x7C;Neutral &#x7C; $217.00&#x7C;$200.00 &#x7C; 
&#x7C;Shyam Patil &#x7C;Susquehanna &#x7C;Raises &#x7C;Neutral &#x7C; $205.00&#x7C;$190.00 &#x7C; 
&#x7C;Brian Pitz &#x7C;BMO Capital &#x7C;Raises &#x7C;Market Perform &#x7C; $190.00&#x7C;$165.00 &#x7C; 
&#x7C;Trevor Young &#x7C;Barclays &#x7C;Raises &#x7C;Equal-Weight &#x7C; $187.00&#x7C;$166.00 &#x7C; 
&#x7C;Deepak Mathivanan &#x7C;Cantor Fitzgerald &#x7C;Raises &#x7C;Neutral &#x7C; $210.00&#x7C;$180.00 &#x7C; 
&#x7C;Jed Kelly &#x7C;Oppenheimer &#x7C;Raises &#x7C;Outperform &#x7C; $235.00&#x7C;$210.00 &#x7C; 
&#x7C;Naved Khan &#x7C;B. Riley Securities &#x7C;Raises &#x7C;Buy &#x7C; $235.00&#x7C;$220.00 &#x7C; 
&#x7C;Daniel Kurnos &#x7C;Benchmark &#x7C;Raises &#x7C;Buy &#x7C; $225.00&#x7C;$200.00 &#x7C; 
&#x7C;Ken Gawrelski &#x7C;Wells Fargo &#x7C;Raises &#x7C;Equal-Weight &#x7C; $199.00&#x7C;$168.00 &#x7C; 
&#x7C;Tom White &#x7C;DA Davidson &#x7C;Raises &#x7C;Neutral &#x7C; $205.00&#x7C;$190.00 &#x7C; 
&#x7C;Daniel Kurnos &#x7C;Benchmark &#x7C;Maintains &#x7C;Buy &#x7C; $200.00&#x7C;$200.00 &#x7C; 
&#x7C;Deepak Mathivanan &#x7C;Cantor Fitzgerald &#x7C;Lowers &#x7C;Neutral &#x7C; $180.00&#x7C;$190.00 &#x7C; 
&#x7C;Ken Gawrelski &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $168.00&#x7C;$172.00 &#x7C; 
&#x7C;Brian Nowak &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Equal-Weight &#x7C; $185.00&#x7C;$180.00 &#x7C; 
&#x7C;Trevor Young &#x7C;Barclays &#x7C;Raises &#x7C;Equal-Weight &#x7C; $166.00&#x7C;$153.00 &#x7C; 
&#x7C;Eric Sheridan &#x7C;Goldman Sachs &#x7C;Raises &#x7C;Buy &#x7C; $236.00&#x7C;$208.00 &#x7C; 
&#x7C;John Staszak &#x7C;Argus Research &#x7C;Raises &#x7C;Buy &#x7C; $220.00&#x7C;$210.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Expedia Group. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Expedia Group compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
To gain a panoramic view of Expedia Group's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/EXPE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Expedia Group analyst ratings.</a>
<h2>Discovering Expedia Group: A Closer Look</h2>
Expedia is the world's second-largest online travel agency by bookings, offering services for lodging (80% of total 2024 sales), air tickets (3%), rental cars, cruises, in-destination, and other (10%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, but its three core online travel agency brands are Expedia, Hotels.com, and Vrbo. It also has a metasearch brand, Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
<h3>Key Indicators: Expedia Group's Financial Health</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Growth: Over the 3M period, Expedia Group showcased positive performance, achieving a revenue growth rate of 10.29% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.
Net Margin: Expedia Group's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 9.39% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Expedia Group's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 20.77%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Expedia Group's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.31% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Expedia Group's debt-to-equity ratio surpasses industry norms, standing at 4.19. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EXPE

Assessing Expedia Group: Insights From 21 Financial Analysts

Hercules Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTGC#NYSE">HTGC</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $20.62, a high estimate of $22.00, and a low estimate of $20.00. Experiencing a 2.69% decline, the current average is now lower than the previous average price target of $21.19. 
<img src="https://www.benzinga.com/files/images/story/2025/1744135239_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
A comprehensive examination of how financial experts perceive Hercules Capital is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;-----------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Paul Johnson &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Outperform &#x7C; $20.50&#x7C;$21.50 &#x7C; 
&#x7C;Crispin Love &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Overweight &#x7C; $20.00&#x7C;$23.00 &#x7C; 
&#x7C;Casey Alexander &#x7C;Compass Point &#x7C;Raises &#x7C;Neutral &#x7C; $20.00&#x7C;$18.25 &#x7C; 
&#x7C;Brian McKenna &#x7C;JMP Securities &#x7C;Maintains &#x7C;Market Outperform&#x7C; $22.00&#x7C;$22.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Hercules Capital. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Hercules Capital compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Hercules Capital's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Hercules Capital's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HTGC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Hercules Capital analyst ratings.</a>
<h2>About Hercules Capital</h2>
Hercules Capital Inc is a specialty finance company that provides senior secured loans to high-growth, venture capital-backed companies in various technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries, including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.
<h3>Hercules Capital: A Financial Overview</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Challenges: Hercules Capital's revenue growth over 3M faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -40.98%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: Hercules Capital's net margin excels beyond industry benchmarks, reaching 74.7%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Hercules Capital's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 3.2%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Hercules Capital's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 1.64%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Hercules Capital's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.9.
<h2>Analyst Ratings: Simplified</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

HTGC

What Analysts Are Saying About Hercules Capital Stock

In the last three months, 6 analysts have published ratings on Webtoon Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBTN#NASDAQ">WBTN</a>), offering a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $14.67, a high estimate of $25.00, and a low estimate of $9.00. Experiencing a 31.51% decline, the current average is now lower than the previous average price target of $21.42. 
<img src="https://www.benzinga.com/files/images/story/2025/1744135228_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The analysis of recent analyst actions sheds light on the perception of Webtoon Entertainment by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Doug Anmuth &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $9.00&#x7C;$10.00 &#x7C; 
&#x7C;Eric Sheridan &#x7C;Goldman Sachs &#x7C;Lowers &#x7C;Buy &#x7C; $15.00&#x7C;$25.00 &#x7C; 
&#x7C;Doug Anmuth &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $10.00&#x7C;$12.00 &#x7C; 
&#x7C;Matthew Cost &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $13.00&#x7C;$16.00 &#x7C; 
&#x7C;Eric Sheridan &#x7C;Goldman Sachs &#x7C;Lowers &#x7C;Buy &#x7C; $25.00&#x7C;$48.00 &#x7C; 
&#x7C;Matthew Cost &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $16.00&#x7C;$17.50 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Webtoon Entertainment. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Webtoon Entertainment compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Webtoon Entertainment's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into Webtoon Entertainment's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/WBTN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Webtoon Entertainment analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Get to Know Webtoon Entertainment Better</h2>
Webtoon Entertainment Inc is a storytelling platform where a vibrant community of creators and users discover, create and share new content. It has pioneered a cultural movement by revolutionizing the storytelling format and democratizing content creation and publication connecting 24 million creators with approximately 170 million monthly active users in over 150 countries around the world.
<h3>Webtoon Entertainment: A Financial Overview</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Positive Revenue Trend: Examining Webtoon Entertainment's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 5.62% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Communication Services sector.
Net Margin: Webtoon Entertainment's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -26.35%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Webtoon Entertainment's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -6.02%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Webtoon Entertainment's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -4.58%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Webtoon Entertainment's debt-to-equity ratio is below the industry average at 0.01, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: Simplified</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

WBTN

Forecasting The Future: 6 Analyst Projections For Webtoon Entertainment

Citigroup's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) short percent of float has risen 11.6% since its last report. The company recently reported that it has 37.99 million shares sold short, which is 2.02% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.92 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Citigroup Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744135226_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Citigroup has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Citigroup's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Citigroup's peer group average for short interest as a percentage of float is 1.19%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Looking Into Citigroup's Recent Short Interest

In the current market session, United States Steel Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) stock price is at $44.27, after a 0.53% decrease. However, over the past month, the company's stock increased by 19.44%, and in the past year, by 3.88%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1744135223_0.png" alt="Past Year Chart" />

<h3>Comparing United States Steel P/E Against Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
United States Steel has a lower P/E than the aggregate P/E of 38.42 of the Metals &amp; Mining industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1744135223_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

News

Intraday Update

Markets

Price Over Earnings Overview: United States Steel

Pinnacle West Capital's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNW#NYSE">PNW</a>) short percent of float has risen 8.36% since its last report. The company recently reported that it has 3.80 million shares sold short, which is 3.63% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.34 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Pinnacle West Capital Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744135222_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Pinnacle West Capital has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Pinnacle West Capital's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Pinnacle West Capital's peer group average for short interest as a percentage of float is 2.22%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Pinnacle West Capital?

Throughout the last three months, 26 analysts have evaluated Expand Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXE#NASDAQ">EXE</a>), offering a diverse set of opinions from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">9</td>
<td align="right">8</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">5</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Expand Energy, presenting an average target of $117.81, a high estimate of $154.00, and a low estimate of $86.00. Observing a 8.56% increase, the current average has risen from the previous average price target of $108.52. 
<img src="https://www.benzinga.com/files/images/story/2025/1744135219_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The standing of Expand Energy among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;-----------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;David Deckelbaum &#x7C;TD Cowen &#x7C;Raises &#x7C;Buy &#x7C; $116.00&#x7C;$108.00 &#x7C; 
&#x7C;Subash Chandra &#x7C;Benchmark &#x7C;Raises &#x7C;Buy &#x7C; $112.00&#x7C;$93.00 &#x7C; 
&#x7C;Roger Read &#x7C;Wells Fargo &#x7C;Raises &#x7C;Equal-Weight &#x7C; $112.00&#x7C;$107.00 &#x7C; 
&#x7C;Nitin Kumar &#x7C;Mizuho &#x7C;Raises &#x7C;Outperform &#x7C; $136.00&#x7C;$132.00 &#x7C; 
&#x7C;Devin McDermott &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Overweight &#x7C; $154.00&#x7C;$137.00 &#x7C; 
&#x7C;Roger Read &#x7C;Wells Fargo &#x7C;Raises &#x7C;Equal-Weight &#x7C; $107.00&#x7C;$105.00 &#x7C; 
&#x7C;Mike Scialla &#x7C;Stephens &amp; Co. &#x7C;Raises &#x7C;Overweight &#x7C; $123.00&#x7C;$86.00 &#x7C; 
&#x7C;Betty Jiang &#x7C;Barclays &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $115.00&#x7C;$117.00 &#x7C; 
&#x7C;Neal Dingmann &#x7C;Truist Securities &#x7C;Lowers &#x7C;Buy &#x7C; $131.00&#x7C;$133.00 &#x7C; 
&#x7C;Zach Parham &#x7C;JP Morgan &#x7C;Lowers &#x7C;Overweight &#x7C; $114.00&#x7C;$115.00 &#x7C; 
&#x7C;Mark Lear &#x7C;Piper Sandler &#x7C;Raises &#x7C;Neutral &#x7C; $101.00&#x7C;$96.00 &#x7C; 
&#x7C;Mike Scialla &#x7C;Stephens &amp; Co. &#x7C;Maintains &#x7C;Equal-Weight &#x7C; $86.00&#x7C;$86.00 &#x7C; 
&#x7C;Betty Jiang &#x7C;Barclays &#x7C;Raises &#x7C;Equal-Weight &#x7C; $117.00&#x7C;$113.00 &#x7C; 
&#x7C;Josh Silverstein &#x7C;UBS &#x7C;Raises &#x7C;Buy &#x7C; $133.00&#x7C;$119.00 &#x7C; 
&#x7C;John Freeman &#x7C;Raymond James &#x7C;Announces &#x7C;Strong Buy &#x7C; $135.00&#x7C;- &#x7C; 
&#x7C;Neil Mehta &#x7C;Goldman Sachs &#x7C;Announces &#x7C;Buy &#x7C; $121.00&#x7C;- &#x7C; 
&#x7C;Betty Jiang &#x7C;Barclays &#x7C;Raises &#x7C;Equal-Weight &#x7C; $113.00&#x7C;$94.00 &#x7C; 
&#x7C;Mark Lear &#x7C;Piper Sandler &#x7C;Announces &#x7C;Neutral &#x7C; $96.00&#x7C;- &#x7C; 
&#x7C;Cameron Bean &#x7C;Scotiabank &#x7C;Raises &#x7C;Sector Outperform&#x7C; $130.00&#x7C;$105.00 &#x7C; 
&#x7C;Paul Diamond &#x7C;Citigroup &#x7C;Raises &#x7C;Buy &#x7C; $125.00&#x7C;$115.00 &#x7C; 
&#x7C;Roger Read &#x7C;Wells Fargo &#x7C;Raises &#x7C;Equal-Weight &#x7C; $105.00&#x7C;$100.00 &#x7C; 
&#x7C;Zach Parham &#x7C;JP Morgan &#x7C;Announces &#x7C;Overweight &#x7C; $112.00&#x7C;- &#x7C; 
&#x7C;Subash Chandra &#x7C;Benchmark &#x7C;Maintains &#x7C;Buy &#x7C; $93.00&#x7C;$93.00 &#x7C; 
&#x7C;Scott Hanold &#x7C;RBC Capital &#x7C;Maintains &#x7C;Outperform &#x7C; $116.00&#x7C;$116.00 &#x7C; 
&#x7C;Neal Dingmann &#x7C;Truist Securities &#x7C;Raises &#x7C;Buy &#x7C; $133.00&#x7C;$109.00 &#x7C; 
&#x7C;Devin McDermott &#x7C;Morgan Stanley &#x7C;Announces &#x7C;Overweight &#x7C; $127.00&#x7C;- &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Expand Energy. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Expand Energy compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Expand Energy's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Expand Energy's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EXE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Expand Energy analyst ratings.</a>
<h2>Unveiling the Story Behind Expand Energy</h2>
Expand Energy Corp independent natural gas producer in the United States. It is fueling a more affordable, reliable and lower-carbon future. The group focused on developing abundant natural gas, oil, and gas liquids to expand energy access.
<h3>Key Indicators: Expand Energy's Financial Health</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Expand Energy's remarkable performance in 3M is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 10.5%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Energy sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Expand Energy's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -19.96%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -2.88%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Expand Energy's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -1.93%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Expand Energy's debt-to-equity ratio is below the industry average at 0.33, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: What Are They?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

26 Analysts Have This To Say About Expand Energy

Popular's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BPOP#NYSE">BPOP</a>) short percent of float has risen 38.73% since its last report. The company recently reported that it has 1.43 million shares sold short, which is 2.4% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.99 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Popular Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744135216_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Popular has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Popular's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Popular's peer group average for short interest as a percentage of float is 3.98%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

BPOP

Is the Market Bullish or Bearish on Popular?

AGCO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGCO#NYSE">AGCO</a>) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $101.56, a high estimate of $118.00, and a low estimate of $88.00. This current average has decreased by 4.09% from the previous average price target of $105.89. 
<img src="https://www.benzinga.com/files/images/story/2025/1744135211_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The analysis of recent analyst actions sheds light on the perception of AGCO by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Jamie Cook &#x7C;Truist Securities &#x7C;Lowers &#x7C;Buy &#x7C; $105.00&#x7C;$125.00 &#x7C; 
&#x7C;Kyle Menges &#x7C;Citigroup &#x7C;Lowers &#x7C;Buy &#x7C; $90.00&#x7C;$98.00 &#x7C; 
&#x7C;Steven Fisher &#x7C;UBS &#x7C;Lowers &#x7C;Neutral &#x7C; $88.00&#x7C;$100.00 &#x7C; 
&#x7C;Kyle Menges &#x7C;Citigroup &#x7C;Raises &#x7C;Neutral &#x7C; $98.00&#x7C;$95.00 &#x7C; 
&#x7C;Mircea Dobre &#x7C;Baird &#x7C;Lowers &#x7C;Neutral &#x7C; $100.00&#x7C;$116.00 &#x7C; 
&#x7C;Kristen Owen &#x7C;Oppenheimer &#x7C;Raises &#x7C;Outperform &#x7C; $109.00&#x7C;$108.00 &#x7C; 
&#x7C;Jamie Cook &#x7C;Truist Securities &#x7C;Raises &#x7C;Buy &#x7C; $118.00&#x7C;$109.00 &#x7C; 
&#x7C;Ann Duignan &#x7C;JP Morgan &#x7C;Raises &#x7C;Overweight &#x7C; $111.00&#x7C;$102.00 &#x7C; 
&#x7C;Kyle Menges &#x7C;Citigroup &#x7C;Lowers &#x7C;Neutral &#x7C; $95.00&#x7C;$100.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to AGCO. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of AGCO compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of AGCO's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of AGCO's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/AGCO/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on AGCO analyst ratings.</a>
<h2>About AGCO</h2>
Agco is a global manufacturer of agricultural equipment. Its main machine brands are Fendt, Massey Ferguson, and Valtra; its initiatives in precision agriculture have been organized under the PTx umbrella following a series of acquisitions. While a global business, Agco's sales skew heavily toward Europe/Middle East, representing 50%-60% of sales and even more of operating profits. The company is trying to increase its exposure to the larger North and South American markets. Its products are available through a global dealer network, which includes over 3,000 dealer and distribution locations and reach into over 140 countries. Additionally, Agco offers retail and wholesale financing to customers through its unconsolidated joint venture with Rabobank of the Netherlands.
<h3>A Deep Dive into AGCO's Financials</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3M period, AGCO faced challenges, resulting in a decline of approximately -24.03% in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: AGCO's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -8.86% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): AGCO's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -6.48% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): AGCO's ROA stands out, surpassing industry averages. With an impressive ROA of -2.07%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: AGCO's debt-to-equity ratio is below the industry average. With a ratio of 0.74, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AGCO

AGCO Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)

Morgan Stanley analyst Meta Marshall maintains Zebra Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBRA#NASDAQ">ZBRA</a>) with a Equal-Weight and lowers the price target from $390 to $232.

Price Target

ZBRA

Morgan Stanley Maintains Equal-Weight on Zebra Technologies, Lowers Price Target to $232

BofA Securities analyst Rafe Jadrosich writes that the building product companies may encounter significant headwinds from tariffs, though the <a href="https://www.benzinga.com/topic/bofa-securities" target="_blank" rel="noreferrer noopener">full impact remains uncertain</a>.
Notably, last week, the Trump administration proposed steep new tariffs on several countries, while maintaining current rates for USMCA-<a href="https://www.benzinga.com/25/04/44589523/trumps-liberation-day-tariff-plan-could-ignite-global-trade-shakeup-betting-markets-price-in-the-pain" target="_blank" rel="noreferrer noopener">compliant goods from Mexico and Canada</a>.
The analyst writes that this announcement poses risks for plumbing firms such as Fortune Brands Innovations, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBIN#NYSE">FBIN</a>) and Masco Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAS#NYSE">MAS</a>) because they&#8217;ve moved production to Southeast Asia and still maintain exposure to China.
Mohawk Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHK#NYSE">MHK</a>) and Whirlpool Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WHR#NYSE">WHR</a>) may be better positioned due to their larger U.S. manufacturing footprint, though they still risk a demand decline in a soft economic environment, adds the analyst.
The analyst estimates an unmitigated 20% hit to EPS for the companies. While pricing could help offset some of the pressure, the broader macroeconomic environment is already tough, adds the analyst.
Jadrosich says that Armstrong World Industries Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AWI#NYSE">AWI</a>) and Owens Corning Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OC#NYSE">OC</a>) are relatively well-positioned to navigate the potential challenges posed by tariffs.
For Armstrong World Industries, Jadrosich notes shares fell 10% over the past three trading days, though there is an estimate of an EPS impact of under 1% due to <a href="https://www.benzinga.com/quote/awi/analyst-ratings" target="_blank" rel="noreferrer noopener">its U.S. manufacturing base</a>.
The company has strong pricing power and a focus on ceiling tile replacements to support resilience, adds the analyst.
The analyst says Mohawk Industries&#8217; stock dropped 13%, but is relatively <a href="https://www.benzinga.com/quote/MHK/analyst-ratings" target="_blank" rel="noreferrer noopener">well positioned versus competitors</a>.
Jadrosich writes that luxury vinyl tile (LVT) competitors may need to raise prices by 20%+ to hold margin margins versus Mohawk Industries&#8217; increase of 1%–2%.
For Owens Corning, the analyst writes that the company&#8217;s roofing (60% of EBITDA), which is domestically produced and linked to replacement demand, <a href="https://www.benzinga.com/quote/oc/analyst-ratings" target="_blank" rel="noreferrer noopener">could gain from lower asphalt prices</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44592073/tariffs-could-shake-building-industry-homebuilders-plumbing-flooring-face-rising-costs" target="_blank" rel="noreferrer noopener">Tariffs Could Shake Building Industry: Homebuilders, Plumbing, Flooring Face Rising Costs</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Equities

Large Cap

Mid Cap

FBIN

What Building Product Companies Are Better Positioned During Tariff Turbulence? BofA Securities Weighs In

Morgan Stanley analyst Meta Marshall maintains Viavi Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>) with a Underweight and lowers the price target from $10 to $8.

VIAV

Morgan Stanley Maintains Underweight on Viavi Solutions, Lowers Price Target to $8

Morgan Stanley analyst Meta Marshall maintains F5 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) with a Equal-Weight and lowers the price target from $310 to $269.

FFIV

Morgan Stanley Maintains Equal-Weight on F5, Lowers Price Target to $269

SHIZA, a company working at the intersection of artificial intelligence and decentralized systems on Tuesday released the open beta version of its &#8220;SHIZA Developer&#8221; platform, a tool designed to enable users to create custom AI agent workflows using a drag-and-drop interface. 
The platform is designed to be accessible to users with varying levels of technical expertise, aiming to simplify the process of building and deploying AI agents.
According to SHIZA, the platform is built on an LLM-agnostic architecture, meaning it&#8217;s designed to work with a variety of language models. 
The company emphasizes ease of use, with a drag-and-drop interface intended to allow individuals to build AI applications without extensive programming knowledge. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44696126/trump-administration-shuts-down-the-department-of-justices-crypto-crime-unit">Trump Administration Shuts Down The Department Of Justice&#8217;s Crypto Crime Unit</a>
The platform is intended to allow the creation of customer support bots, personal assistants, and task automation tools.
&#8220;Before you can own your AI, you need to be able to build your AI,&#8221; said Syed Hussain, Founder and CEO of SHIZA, in a statement. &#8220;This open beta marks a major step forward in our mission to make powerful AI accessible, flexible, and easy to build with.&#8221;
SHIZA is also developing a &#8220;Knowledge-as-a-Service&#8221; marketplace, where users can potentially trade and monetize their custom knowledge stores (&#8220;Intellects&#8221;). 
The company believes this system allows users to retain full ownership of their intellectual contributions. A consumer-facing dashboard application called SHIZA Companion, currently in the prototype stage, is also planned.
The SHIZA team has backgrounds in capital markets, Web3, data analytics, AI, and machine learning.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44692019/ripple-acquires-prime-broker-hidden-road-for-1-25-billion">Ripple Acquires Prime Broker Hidden Road For $1.25 Billion</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

SHIZA Launches Open Beta For Drag-And-Drop Agentic AI Workflow Builder

Morgan Stanley analyst Meta Marshall maintains Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) with a Overweight and lowers the price target from $118 to $73.

ANET

Morgan Stanley Maintains Overweight on Arista Networks, Lowers Price Target to $73

Politics

Movers

General

Markets Move Higher; Trump Administration Considering Softening Proposed Fee On China-Linked Ships Visiting U.S. Ports

Macro investment strategist Raoul Pal believes the recent crypto market pullback is far from a cause for panic and could, in fact, be <a href="https://www.benzinga.com/money/bitcoin-price-prediction">a rare entry point</a> for Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) investors.
What Happened: Speaking in a podcast on April 7, Pal <a href="https://www.youtube.com/watch?v=_7yuo6JRexY">said</a> investor sentiment hasn&#8217;t yet reached the &#8220;peak fear&#8221; levels last seen during the COVID-19 crash, but it's getting close—and that&#8217;s exactly when big opportunities arise.
He pointed out that Bitcoin has endured seven pullbacks of 20%–30% over the past two and a half years, including two 30% drops, one 35%, and two 40% corrections in 2017 alone, yet still posted extraordinary returns that year.
"You probably don't remember any of the other ones," Pal said, "because once the market recovers, they vanish from memory."
The Macro View
Pal's investment thesis, known as &#8220;The Everything Code,&#8221; revolves around global liquidity as the primary market driver, not the Fed. He explained that the need to service aging government debt structures fuels liquidity injections, which ultimately pushes asset prices higher.
"The Fed cut is a red herring," Pal said. "It's delayed versus actual liquidity. What really matters is financial conditions and they've been easing fast."
He expects this trend to continue as political uncertainties, such as Trump's sweeping tariff threats, begins to stabilize through negotiations and rollbacks, removing friction from the markets.
Also Read: <a href="https://in.benzinga.com/markets/cryptocurrency/25/04/44681738/bitcoin-is-a-more-liquid-and-higher-volatility-version-of-gold-bernstein">Bitcoin Is A &#8216;More Liquid And Higher Volatility Version Of Gold&#8217;: Bernstein</a>
Why It Matters: For crypto investors, Pal&#8217;s message is loud and clear: this isn&#8217;t the start of a prolonged bear market, it's a setup.
"We're in a time that is almost as ‘peak fear' as COVID was… these things don't come often, but when they come, they're a goddamn gift."
He views current conditions, both sentiment-driven and macroeconomics, aligning for a potential strong rebound in the months ahead.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44686556/bitcoin-reclaims-80000-what-does-technical-analysis-say">Bitcoin Reclaims $80,000: What Does Technical Analysis Say?</a></li>
</ul>
Image: Shutterstock

$BTC

Raoul Pal Says Crypto Market Nowhere Near COVID-19 'Peak Fear'

<a href="https://www.youtube.com/watch?v=u20MejkkeLU">LIVE: White House Press Secretary Karoline Leavitt Holds a Press Briefing - 4/8/25</a>

Macro Economic Events

Global

Economics

White House Press Secretary Karoline Leavitt Says Israel's Netanyahu Pledged To Eliminate U.S Trade Deficit; Says Trump Believes China Has To Make Deal With U.S.

Comments

Corix Bioscience

Notizie

Ultime notizie per Corix Bioscience (OTC:CXBS) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO